# Cornelius Merlini

> Cornelius Merlini is a Series A investor at Intrinsic Capital Partners backing Industrial. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Intrinsic Capital Partners](https://shizune.co/investors/profile/intrinsic-capital-partners)
- Location: Philadelphia, United States
- Total investments: 1
- Last investment: Nov 2022
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/cornelius-merlini-a139691b/

Cornelius Merlini is a Managing Partner and Founder at Intrinsic Capital Partners. He Attended Villanova University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Industrial | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |
| Product Research | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| QNTM Labs | QNTM Labs provides research, development, and regulatory compliance services for pharmaceutical companies. They improve transparency and access to robust scientific analysis, working with global researchers, API manufacturers, and pharmaceutical industry stakeholders through analytical testing, contract research, and clinical trial support. Theyoffer R&D testing, quality control testing, and contract research. |  | Series A | Nov 17, 2022 |  |

1 of 1 investments shown.

## About Intrinsic Capital Partners

VC Fund · Philadelphia, United States

Intrinsic Capital Partners is a private equity fund dedicated to investing in promising growth businesses in the emerging legal cannabis industry. Their team has years of investment, pharmaceutical, regulatory, and deal structure experience. Along with our world class network of operating partners with decades of experience building businesses andbrands across healthcare and consumer industries, they are dedicated to creating value for portfolio company owners while generating superior returns for our fund investors.

3 contacts available at Intrinsic Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Cornelius Merlini | Managing Partner & Founder | https://shizune.co/investors/profile/cornelius-merlini-3d92 |
| Gerald F Stahlecker | Partner & Founder | https://shizune.co/investors/profile/gerald-f-stahlecker |
| Howard Goodwin | Partner & Founder | https://shizune.co/investors/profile/howard-goodwin |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Cornelius Merlini invest in?

Cornelius Merlini invests primarily in Industrial, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cornelius Merlini last invest?

The most recent investment recorded for Cornelius Merlini closed in Nov 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co